Condition
Bacteriophage Therapy
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Not Yet Recruiting2
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07461337Phase 1Not Yet Recruiting
Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection
NCT07429162Phase 1Not Yet Recruiting
Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection
NCT05314426Enrolling By InvitationPrimary
Mayo Clinic Phage Program Biobank
Showing all 3 trials